Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Total Equity

Adverum Biotechnlgs Total Equity Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Total Equity from 2013 to 2020.
  • Adverum Biotechnlgs Total Equity for the quarter ending June 06, 2020 was $283m a 41.88% increase of 118m year over year
  • Adverum Biotechnlgs Total Equity for the last 12 months ending June 06, 2020 was $283m a 41.88% increase of 118m year over year
  • Adverum Biotechnlgs Annual Total Equity for 2019 was $175m a -14.98% decrease of -26m from 2018
  • Adverum Biotechnlgs Annual Total Equity for 2018 was $201m a 8.52% increase of 17m from 2017
  • Adverum Biotechnlgs Annual Total Equity for 2017 was $184m a -17.16% decrease of -32m from 2016
Other Balance Sheet Metrics:
  • Adverum Biotechnlgs Total Assets for the quarter ending September 09, 2018 was $226m a 10.62% increase of 24m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
View Chart On Koyfin

Quarterly ADVM Total Equity Data

06/2020$283m
03/2020$304m
12/2019$175m
09/2019$164m
06/2019$178m
03/2019$188m
12/2018$201m
09/2018$216m
06/2018$233m
03/2018$246m

Annual ADVM Total Equity Data

2019$175m
2018$201m
2017$184m
2016$216m
2015$253m
2014$149m
2013$0m
2012$-1m